SEC Form 4 · accession 0001213900-17-008214
ORAMED PHARMACEUTICALS INC. · ORMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Xiaopeng Li
Director
Period of report
Aug 2, 2017
Accepted (ET)
Aug 3, 2017 · 6:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001176309
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | Aug 2, 2017 | P | 89,636 | $8.50 | A | 206,350 | D |
Table II — derivative securities
No Table II lines on this filing.